Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 197

    1.

    Mental retardation and developmental disabilities influenced by environmental neurotoxic insults.

    Schroeder SR.

    Environ Health Perspect. 2000 Jun;108 Suppl 3:395-9. Review.PMID: 10852834 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chemicals in the environment and developmental toxicity to children: a public health and policy perspective.

    Goldman LR, Koduru S.

    Environ Health Perspect. 2000 Jun;108 Suppl 3:443-8.PMID: 10852843 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Developmental neurotoxicity. Illustration of principles.

    Bearer CF.

    Pediatr Clin North Am. 2001 Oct;48(5):1199-213, ix. Review.PMID: 11579669 [PubMed - indexed for MEDLINE]Related articles

    4.

    Workshop to identify critical windows of exposure for children's health: neurobehavioral work group summary.

    Adams J, Barone S Jr, LaMantia A, Philen R, Rice DC, Spear L, Susser E.

    Environ Health Perspect. 2000 Jun;108 Suppl 3:535-44. Review.PMID: 10852852 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Developmental considerations of neurotoxic exposures.

    Trask CL, Kosofsky BE.

    Neurol Clin. 2000 Aug;18(3):541-62. Review.PMID: 10873230 [PubMed - indexed for MEDLINE]Related articles

    6.

    Applied biomedical research in mental retardation--prevention.

    Coons CE, Frankenburg WK.

    Appl Res Ment Retard. 1982;3(3):221-31.PMID: 6184016 [PubMed - indexed for MEDLINE]Related articles

    7.

    Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.

    Rice D, Barone S Jr.

    Environ Health Perspect. 2000 Jun;108 Suppl 3:511-33. Review.PMID: 10852851 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

    Aman MG, Gharabawi GM; Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients With Mental Retardation and Developmental Disabilities.

    J Clin Psychiatry. 2004 Sep;65(9):1197-210. Review.PMID: 15367046 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevalence of mental retardation and developmental disabilities: estimates from the 1994/1995 National Health Interview Survey Disability Supplements.

    Larson SA, Lakin KC, Anderson L, Kwak N, Lee JH, Anderson D.

    Am J Ment Retard. 2001 May;106(3):231-52.PMID: 11408960 [PubMed - indexed for MEDLINE]Related articles

    10.

    A biogenic amine-synapse mechanism for mental retardation and developmental disabilities.

    Okado N, Narita M, Narita N.

    Brain Dev. 2001 Dec;23 Suppl 1:S11-5. Review.PMID: 11738835 [PubMed - indexed for MEDLINE]Related articles

    11.

    Does methylmercury have a role in causing developmental disabilities in children?

    Myers GJ, Davidson PW.

    Environ Health Perspect. 2000 Jun;108 Suppl 3:413-20. Review.PMID: 10852838 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevalence of four developmental disabilities among children aged 8 years--Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000.

    Bhasin TK, Brocksen S, Avchen RN, Van Naarden Braun K.

    MMWR Surveill Summ. 2006 Jan 27;55(1):1-9. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Feb 3;55(4):105-6. PMID: 16437058 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Technology and the environment: supportive resource or barrier for people with developmental disabilities?

    Hammel J.

    Nurs Clin North Am. 2003 Jun;38(2):331-49. Review.PMID: 12914311 [PubMed - indexed for MEDLINE]Related articles

    14.

    The epidemiology of developmental disabilities in low-income countries.

    Durkin M.

    Ment Retard Dev Disabil Res Rev. 2002;8(3):206-11.PMID: 12216065 [PubMed - indexed for MEDLINE]Related articles

    15.

    Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation, and dysmorphic features.

    Aradhya S, Manning MA, Splendore A, Cherry AM.

    Am J Med Genet A. 2007 Jul 1;143A(13):1431-41.PMID: 17568414 [PubMed - indexed for MEDLINE]Related articles

    16.

    Positron emission tomography methods with potential for increased understanding of mental retardation and developmental disabilities.

    Sundaram SK, Chugani HT, Chugani DC.

    Ment Retard Dev Disabil Res Rev. 2005;11(4):325-30. Review.PMID: 16240413 [PubMed - indexed for MEDLINE]Related articles

    17.

    Applications of gene targeting technology to mental retardation and developmental disability research.

    Pimenta AF, Levitt P.

    Ment Retard Dev Disabil Res Rev. 2005;11(4):295-302. Review.PMID: 16240411 [PubMed - indexed for MEDLINE]Related articles

    18.

    Autistic and developmental disorders after general anaesthetic delivery.

    Hattori R, Desimaru M, Nagayama I, Inoue K.

    Lancet. 1991 Jun 1;337(8753):1357-8. No abstract available. PMID: 1709436 [PubMed - indexed for MEDLINE]Related articles

    19.

    New horizons: future directions in neurotoxicology.

    Tilson HA.

    Environ Health Perspect. 2000 Jun;108 Suppl 3:439-41.PMID: 10852842 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Environmental factors associated with a spectrum of neurodevelopmental deficits.

    Mendola P, Selevan SG, Gutter S, Rice D.

    Ment Retard Dev Disabil Res Rev. 2002;8(3):188-97. Review.PMID: 12216063 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data